Ongoing for 13 years, the NCCS Cancer Policy Roundtable is a biannual cancer care policy forum that brings together patient advocates from the cancer community, researchers, clinicians, academicians, policymakers, and a diverse group of biotechnology and pharmaceutical companies to discuss current and emerging issues that influence cancer research, development of new cancer therapies, and the delivery of and access to quality cancer care.
The faculty that present at the Cancer Policy Roundtable range from public and health policy experts to representatives from the National Institutes of Health, Food and Drug Administration, Centers for Medicare and Medicaid Services, Congressional Health Policy Advisors and leaders in health insurance, pharmaceutical, and biotechnology industries.
These meetings are a great opportunity for interested parties to come together and discuss timely and compelling issues. Specific objectives and outcomes are unique to each meeting, however past meetings have focused on topics such as clinical trials, expanded access programs, Medicare reimbursement, healthcare reform and other relevant topics.
Sponsors and Memberships
For more information on how to become a participant of this event, please contact us.